[Gp130-activating mutations in inflammatory liver adenomas]

Med Sci (Paris). 2008 Dec;24(12):1113-4. doi: 10.1051/medsci/200824121113.
[Article in French]
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / chemically induced
  • Adenoma / genetics*
  • Adult
  • Carcinoma, Hepatocellular / genetics
  • Chemical and Drug Induced Liver Injury / etiology
  • Chemical and Drug Induced Liver Injury / genetics*
  • Contraceptives, Oral, Hormonal / adverse effects
  • Cytokine Receptor gp130 / genetics*
  • Cytokine Receptor gp130 / physiology
  • Disease Progression
  • Female
  • Gene Expression Regulation, Neoplastic
  • Hepatocyte Nuclear Factor 1-alpha / physiology
  • Humans
  • Inflammation Mediators / metabolism
  • Interleukin-6 / physiology
  • Liver Neoplasms / chemically induced
  • Liver Neoplasms / genetics*
  • Mutation
  • Neoplasm Proteins / genetics*
  • Neoplasm Proteins / physiology
  • STAT3 Transcription Factor / physiology
  • Sequence Deletion
  • Wnt Proteins / physiology
  • Young Adult
  • beta Catenin / physiology

Substances

  • CTNNB1 protein, human
  • Contraceptives, Oral, Hormonal
  • Hepatocyte Nuclear Factor 1-alpha
  • IL6 protein, human
  • IL6ST protein, human
  • Inflammation Mediators
  • Interleukin-6
  • Neoplasm Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Wnt Proteins
  • beta Catenin
  • Cytokine Receptor gp130